A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
PHASE2
To explore the Efficacy and Safety of Tislelizumab combined with fruquintin...
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
PHASE2
A prospective, randomized, open-label, multicenter Phase 2 trial designed t...
Status
Recruiting
Location
Medical Ethics Committee of Sun Yat-sen Memorial Hospital
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE2
For peritoneal metastatic gastric/gastroesophageal junction adenocarcinoma ...